Correspondence 0001493152-22-032897 from RenovoRx, Inc. (RNXT)
RenovoRx, Inc.
Date: Nov. 18, 2022 · CIK: 0001574094 · Accession: 0001493152-22-032897
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-268302
Letter
RenovoRx, Inc.
El Camino Real, Suite B1
Los Altos, California 94022
November 18, 2022
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
F Street, N.E.
Washington, D.C. 20549
Re: RenovoRx, Inc.
Registration Statement on Form S-3
Filed November 10, 2022
File No. 333-268302
Acceleration Request
Requested Date: November 21, 2022
Requested Time: 4:00 p.m. Eastern Time,
or as soon thereafter as practicable
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, RenovoRx, Inc. (the “Company”) hereby respectfully requests that the above-referenced Registration Statement on Form S-3 (File No. 333-268302) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission.
Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, Professional Corporation, by calling Michael Coke at (650) 565-3596.
Please direct any questions or comments regarding this acceleration request to Michael Coke.
Very
truly yours,
RenovoRx,
Inc.
Show Raw Text
CORRESP
1
filename1.htm
RenovoRx,
Inc.
4546
El Camino Real, Suite B1
Los
Altos, California 94022
November
18, 2022
VIA
EDGAR
Securities
and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
D.C. 20549
Re:
RenovoRx,
Inc.
Registration
Statement on Form S-3
Filed
November 10, 2022
File
No. 333-268302
Acceleration Request
Requested
Date:
November
21, 2022
Requested
Time:
4:00
p.m. Eastern Time,
or
as soon thereafter as practicable
Ladies
and Gentlemen:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended, RenovoRx, Inc. (the “Company”) hereby respectfully requests
that the above-referenced Registration Statement on Form S-3 (File No. 333-268302) (the “Registration Statement”)
be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the
Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and
Exchange Commission.
Once
the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich &
Rosati, Professional Corporation, by calling Michael Coke at (650) 565-3596.
Please
direct any questions or comments regarding this acceleration request to Michael Coke.
Very
truly yours,
RenovoRx,
Inc.
/s/
Shaun R. Bagai
Shaun
R. Bagai
Chief
Executive Officer
cc:
Michael
E. Coke, Wilson Sonsini Goodrich & Rosati, Professional Corporation